Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB ( IkappaB-alphaS32/36A ) and the implications for vaccine development .
potent and stable attenuation of live-hiv-1 by gain of a proteolysis-resistant inhibitor of nf-kappab ( ikappab-alphas32/36a ) and the implications for vaccine development .
O O O O O B-virus O O O O B-protein_family_or_group I-protein_family_or_group O B-protein_complex O B-protein_molecule O O O O O B-other_name I-other_name O